S.N. Vyshelesski Institute of Experimental Veterinary offers consumers a complex antiviral, antibacterial and immunostimulating drug for the prevention and treatment of pneumoenteritis in young pigs "Argolaferrin" under a manufacturing agreement and is looking for partners interested in a distribution services agreement.

The complex preparation "Argolaferrin" was developed on the basis of recombinant lactoferrin and silver nanoparticles. The concentration of recombinant lactoferrin in the preparation was 10 mg/ml, silver nanoparticles - 0.5 mg/ml. The drug has no cytotoxic effect on SPEV and MDBK cell cultures; 20.3..35.9%, B-lymphocytes - by 49.4..65.4%, an increase in the level of bactericidal and lysozyme activity of blood serum - by 3.4..7.4 and 7.4..8 .9%, respectively, phagocytic activity of leukocytes - by 11.7..19.5%. The results of production tests of the therapeutic and prophylactic efficacy of the drug confirmed its high efficiency in the prevention and treatment of pneumoenteritis in young pigs (therapeutic - 85.5..90.0%, prophylactic - 90.7..95%).

The economic effect of carrying out therapeutic and preventive measures with the use of a new complex drug is 5 rubles. for 1 ruble of expenses.

Specifications for the complex preparation "Argolaferrin" (TU BY 600049853.285-2015), instructions for use, guidelines for the prevention and treatment of pneumoenteritis in young pigs using complex preparations have been developed.

The high level of development of animal husbandry in the Republic of Belarus is largely ensured by the efforts of veterinary medicine and its scientific and methodological center, which is the Republican Unitary Enterprise “S.N. Vyshelesski Institute of Experimental Veterinary".

Areas of activity of the Institute:
✔ development and improvement of methods for diagnosis, prevention, treatment, measures to combat infectious, parasitic and non-contagious diseases of farm animals, birds, bees;
✔ creation of modern vaccines, highly specific diagnostics, drugs, metabolic correction agents that provide veterinary protection of animals and obtain environmentally friendly livestock products;
✔ provision of scientific and practical assistance to the farms of the republic;
✔ training of highly qualified scientific personnel.

The tasks facing the Institute:
✔ conducting fundamental and applied research in the field of veterinary medicine in accordance with the main directions of economic and social development of the agro-industrial complex of the Republic of Belarus;
✔ conducting fundamental and applied research to study the mechanisms of immunity formation and the development of methods for its directed regulation;
✔ development of forecasts and programs for veterinary medicine;
✔ epizootological monitoring of the most common and parasitic infectious animal diseases, development of short-term and long-term forecasts of their occurrence and degree of manifestation;
✔ development of new and improvement of existing competitive means and methods for the diagnosis, prevention and treatment of infectious, parasitic and non-contagious animal diseases, the creation of integrated systems that ensure the protection of human health, the veterinary welfare of animal husbandry, obtaining environmentally friendly and high sanitary quality livestock products;
✔ isolation and study of the genetic, molecular and biological properties of pathogens of infectious diseases, selection and collection of useful strains that are promising for the creation of diagnosticums and vaccines;
✔ development of technologies for the production of veterinary drugs, vaccines, chemicals, antiparasitic agents.

Consumers interested in purchasing of the complex preparation of antiviral, antibacterial and immunostimulating action for the prevention and treatment of pneumoenteritis in young pigs "Argolaferrin" under a manufacturing agreement.

Partners interested in purchasing of the complex preparation of antiviral, antibacterial and immunostimulating action for the prevention and treatment of pneumoenteritis in young pigs "Argolaferrin" under a distribution services agreement .